XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Statements of Operations (Unaudited) (Parenthetical) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Defined Benefit Plan Disclosure [Line Items]    
Cost of Revenue $ 26,754 $ 100,848
Research and Development Expense 2,084,648 1,698,883
Related Party [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Cost of Revenue 46,762
Research and Development Expense $ 375,193 $ 77,463